About the Lab

Broadening Therapeutic Gene Transfer Through Mechanistic Studies, Technology Development, and Translation to the Clinic

Gene therapy is a conceptually naïve approach that has proven difficult in execution. It is the bringing together of a molecular intervention to a disease target by the delivery of a gene. Over 40 years in the making, clinical studies over the past years have illustrated the transformative potential of gene therapy in inherited blindness, hemophilia, and motor neuron disease.

Research in the Vandenberghe laboratory is focused on broadening applications of gene therapy generally. Research is centered on three overlapping areas of focus: Mechanism, Technology, and Translation.

Past and Current Funding

  • Harvard Medical School, Department of Ophthalmology
  • Massachusetts Eye and Ear Associates
  • National Institutes of Health, Director’s Office
  • National Institutes of Health, National Eye Institute
  • Foundation Fighting Blindness
  • Research To Prevent Blindness
  • Curing Kids Fund
  • Foundation For Retina Research
  • Grousbeck Family Foundation
  • Henwood Gene Therapy Research Fund
  • Ush2A Consortium
  • The Butler Foundation
  • Jonathan Kutchins
  • Lonza Houston
  • Selecta Biosciences
  • British Heart Foundation

  • Luk H. Vandenberghe, PhD

    Director

    Read Bio